Five years follow-up of schoolchildren infected with schistosomiasis in Niger: evidence of the benefit of a regular praziquantel administration on the reinfection
2011

Long-term effects of praziquantel treatment on schistosomiasis in schoolchildren

Sample size: 1017 publication Evidence: high

Author Information

Author(s): Tohon Zilahatou, Boubacar Halima, Yahaya Ramatou, Abdou Biba, Boisier Pascal

Primary Institution: Unité d’Epidémiologie, Centre de Recherche Médicale et Sanitaire, BP 10887 Niamey, Niger

Hypothesis

Does regular praziquantel administration reduce schistosomiasis reinfection rates in schoolchildren?

Conclusion

Regular praziquantel treatment significantly reduced the prevalence and intensity of schistosomiasis and its related complications over five years.

Supporting Evidence

  • At baseline, S. haematobium infection prevalence was 76.8% among the 1017 enrolled schoolchildren.
  • After 4 and 5 years of follow-up, urinary schistosomiasis was retrieved among 44.3% and 26.5% of the children, respectively.
  • 23.0% of uninfected schoolchildren at baseline became infected at year 4.
  • 48% of schoolchildren with positive egg count at baseline were found negative at year 4.
  • Prevalence of anaemia was reduced to 51.8%, 40.5%, and 25.9% at years 2, 3, and 5 of follow-up, respectively.
  • The prevalence of ultrasound bladder abnormalities dropped from 37.7% at baseline to 2.6% at year 5.

Takeaway

Giving schoolchildren medicine regularly helps them stay healthy by reducing the number of worms in their bodies.

Methodology

A longitudinal follow-up study with annual assessments of schistosomiasis prevalence and related morbidity among schoolchildren.

Participant Demographics

Schoolchildren from 5 endemic villages in Niger.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1753-6561-5-S1-P57

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication